Hostname: page-component-cd9895bd7-lnqnp Total loading time: 0 Render date: 2024-12-25T19:05:33.187Z Has data issue: false hasContentIssue false
  • English
  • Français

Development of a Health Screening Clinic

Published online by Cambridge University Press:  16 April 2020

H.L. Millar
H.L. Millar*
Affiliation:
Carseview Centre, 4 Tom McDonald Avenue, Dundee, DD2 1NH, United-Kingdom
*
Correspondence. Tel.: +44 (0) 1382 878796. E-mail address: h.millar@nhs.net
Get access

Abstract

Medical morbidity and mortality levels remain elevated in people with schizophrenia compared with the general population. Despite the increasing recognition of an excess of physical health problems in this population, health screening remains limited. Medical risk in this population can be related to a variety of sources. The disease process itself as well as poor diet and sedentary lifestyle contribute to the overall physical health problems. In addition antipsychotic medication can contribute to the risk of cardiovascular and metabolic problems. The Dundee Health Screening Clinic was developed to address the needs of this population by monitoring physical health and providing follow-up to ensure that patients received the necessary care. The Clinic demonstrates how a coordinated approach can be used to take simple steps to improve the overall well-being of these patients. It was set up by adapting the manpower resources and procedures of the community mental health team and local resource centre, without specific additional funding. Simple clinical measurements and tests were conducted in the Clinic and patients clearly demonstrated on a satisfaction questionnaire that they considered the health checks important. This Clinic is an example of how a holistic approach can impact on both the physical and mental well-being of patients and offer them improved care and therefore a better quality of life.

Keywords

SchizophreniaHealth screeningPhysical health
Type
Research Article
Information
European Psychiatry , Volume 25 , Issue S2: Physical health in patients with schizophrenia: current knowledge and practical recommendations , June 2010 , pp. S29 - S33
Copyright
Copyright © 2010 Elsevier Masson SAS

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Alberti, K.G.Zimmet, P.Shaw, J.The metabolic syndrome-a new worldwide definition. Lancet 2005; 366: 1059–1062CrossRefGoogle ScholarPubMed
Barnett, A.H.Mackin, P.Chaudhry, I.Farooqi, A.Gadsby, R.Heald, A., et al.Minimising metabolic and cardiovascular risk in schizophrenia: diabetes, obesity and dyslipidaemia. J Psychopharmacol 2007; 21: 357–373CrossRefGoogle ScholarPubMed
Bennett, J.Done, J.Hunt, B.Assessing the side-effects of antipsychotic drugs: a survey of CPN practice. J Psychiatr Ment Health Nurs 1995; 2: 177–182CrossRefGoogle ScholarPubMed
Brown, S.Excess mortality of schizophrenia. A meta-analysis. Br J Psychiatry 1997; 171: 502–508CrossRefGoogle ScholarPubMed
Brown, S.Birtwistle, J.Roe, L.Thompson, C.The unhealthy lifestyle of people with schizophrenia. Psychol Med 1999; 29: 697–701CrossRefGoogle ScholarPubMed
Brown, S.Inskip, H.Barraclough, B.Causes of the excess mortality of schizophrenia. Br J Psychiatry 2000; 177: 212–217CrossRefGoogle ScholarPubMed
Davidson, S.Judd, F.Jolley, D.Hocking, B.Thompson, S.Hyland, B.Risk factors for HIV/AIDS and hepatitis C among the chronic mentally ill. Aust N Z J Psychiatry 2001; 35: 203–209CrossRefGoogle ScholarPubMed
Druss, B.E.Bradford, W.D.Rosenheck, R.A.Radford, M.J.Krumholz, H.M.Quality of medical care and excess mortality in older patients with mental disorders. Arch Gen Psychiatry 2001; 58: 572CrossRefGoogle ScholarPubMed
Goldman, L.S.Medical illness in patients with schizophrenia. J Clin Psychiatry 1999; 60(Suppl. 21): 10–15Google ScholarPubMed
Gough, S.C.O’Donovan, M.C.Clustering of metabolic comorbidity in schizophrenia: a genetic contribution? J Psychopharmacol 2005; 19(6 Suppl.): 47–55CrossRefGoogle ScholarPubMed
Halbreich, U.Shen, J.Panaro, V.Are chronic psychiatric patients at increased risk for developing breast cancer? Am J Psychiatry 1996; 153: 559–560Google ScholarPubMed
Hennekens, C.H.Hennekens, A.R.Hollar, D.Casey, D.E.Schizophrenia and increased risks of cardiovascular disease. Am Heart J 2005; 150: 1115–1121CrossRefGoogle ScholarPubMed
Hogan, T.P.Awad, A.G.Eastwood, R.A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychol Med 1983; 13: 177–183CrossRefGoogle ScholarPubMed
Koro, C.E.Fedder, D.O.L’Italien, G.J.Weiss, S.Magder, L.S.Kreyenbuhl, J., et al.An assessment of the independent effects of olanzapine and risperidone exposure on the risk of hyperlipidemia in schizophrenic patients. Arch Gen Psychiatry 2002; 59: 1021–1026CrossRefGoogle ScholarPubMed
Lambert, T.J.Velakoulis, D.Pantelis, C.Medical comorbidity in schizophrenia. Med J Aust 2003; 178: S67–S70CrossRefGoogle Scholar
McCreadie, R.G.Diet, smoking and cardiovascular risk in people with schizophrenia: descriptive study. Br J Psychiatry 2003; 183: 534–539Google ScholarPubMed
National Collaborating Centre for Chronic Conditions. Clinical Guidelines for type 2 diabetes mellitus: management of blood glucose. London: Royal College of Physicians: 2008Google Scholar
Newcomer, J.W.Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs 2005; 19(Suppl. 1): 1–93CrossRefGoogle ScholarPubMed
Newcomer, J.W.Metabolic considerations in the use of antipsychotic medications: a review of recent evidence. J Clin Psychiatry 2007; 68(Suppl. 1): 20–27Google ScholarPubMed
Newman, S.C.Bland, R.C.Mortality in a cohort of patients with schizophrenia: a record linkage study. Can J Psychiatry 1991; 36: 239–245CrossRefGoogle Scholar
Paton, C.Esop, R.Young, C.Taylor, D.Obesity, dyslipidaemias and smoking in an inpatient population treated with antipsychotic drugs. Acta Psychiatr Scand 2004; 110: 299–305CrossRefGoogle Scholar
Thakore, J.H.Mann, J.N.Vlahos, I.Martin, A.Reznek, R.Increased visceral fat distribution in drug-naive and drug-free patients with schizophrenia. Int J Obes Relat Metab Disord 2002; 26: 137–141CrossRefGoogle ScholarPubMed
UK Department of Health. Choosing Health : Support the physical health of people with severe mental illness, Commissioning framework; 2006.Google Scholar
Submit a response

Comments

No Comments have been published for this article.